[Methodological features of assessing the effectiveness of adjuvant therapy in clinical trials].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality; D002986:Clinical Trials as Topic / Q000379:methods; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011336:Probability; D011897:Random Allocation; D012306:Risk
D000970:Antineoplastic Agents
Metodicheskie osobennosti otsenki éffektivnosti dopolnitel'noĭ terapii pri klinicheskikh ispytaniiakh.